Marie Hudson
Research Scientist, MD, MPH, FRCPC
Appointments
- Clinician-scientist, Jewish General Hospital and Lady Davis Institute
- Associate Professor, Department of Medicine, McGill University
Research Interests
-
Systemic autoimmune rheumatic diseases
Dr. Hudson received her MD from McGill University, where she completed her residency training in internal medicine and rheumatology. She subsequently obtained a Master’s degree in Public Health from Columbia University in New York, and then returned to McGill to pursue a post-doctoral fellowship in epidemiology. Dr. Hudson is a fellow of the Royal College of Physicians and Surgeons of Canada and has received the prestigious New Investigator Award from the Canadian Institutes of Health Research.
Dr. Hudson pursues research in systemic autoimmune rheumatic diseases. In particular, she is one of the founding members of the Canadian Scleroderma Research Group (CSRG), a CIHR-funded, multi-centre group of researchers that follows a cohort of over 1600 SSc patients across Canada. She has published landmark studies documenting the magnitude of impairment in health-related quality of life (HRQoL) with scleroderma. She is particularly interested in scleroderma lung disease, its natural history, its optimal treatment, and its impact on HRQoL. She is currently developing a novel translational and clinical research program focused on cellular therapies for SSc. Dr Hudson is also involved in a number of studies in other rheumatic diseases, including inflammatory myositis, rheumatoid arthritis and rheumatic-immune related adverse events resulting from cancer immunotherapy. She is the recipient of the 2011 Canadian Rheumatology Association Young Investigator Award.Learn more
Recent News Coverage
Dr. Diane Lacaille Interview – CHTM Thompson – Arthritis Awareness Month
Arthritis Research Canada's Scientific Director, Dr. Diane Lacaille chats with 102.9 CHTM Thompson about Arthritis Awareness Month.Part one of interview Part two of...
I’m Dr. Diane Lacaille, Ask Me Anything
I'm Dr. Diane Lacaille, Ask Me Anything Do you have questions about arthritis? Our Reddit AMA with Dr. Diane Lacaille is now complete. Please click here to view the AMA. Join Dr. Diane Lacaille, Scientific Director, Arthritis Research Canada, for a Reddit...
Arthritis Research Canada Welcomes Joy MacPhail and Jordan Langlois to the Organization’s Board of Directors
Arthritis Research Canada welcomes Joy MacPhail and Jordan Langlois to the organization's board of directors July 14, 2020 (Vancouver, BC) – Arthritis Research Canada is delighted to welcome two new members to our Board of Directors – Joy MacPhail and Jordan Langlois....
Le fondateur et directeur scientifique d’Arthrite-recherche Canada passe le relais à sa successeure.
Le fondateur et directeur scientifique d’Arthrite-recherche Canada passe le relais à sa successeure le 7 juillet 2020 (Vancouver, C. - B) – Après 21 ans à la tête d’Arthrite-recherche Canada/Arthritis Research Canada en tant que directeur scientifique, le Dr John...
Arthritis Research Funding Highlights
Arthritis Research Funding Highlights Dr. Cheryl Barnabe (Arthritis Research Canada, Alberta) is Canada’s leader in research relating to the health of the indigenous community. Dr. Barnabe as Co-Principal Investigator with Cara Bablitz, Lynden Crowshoe, Michael Green,...
Arthritis Research Canada creator and scientific director passes the baton to successor.
Arthritis Research Canada creator and scientific director passes the baton to successor July 7, 2020 (Vancouver, BC) – After 21 years as Arthritis Research Canada/Arthrite-recherche Canada’s scientific director, world-renowned scientist and rheumatologist, Dr. John...
Evaluating the safety and efficacy of biosimilars to help shape future health policies
Evaluating the safety and efficacy of biosimilars to help shape future health policies June 17, 2020 (Vancouver, BC) – Biosimilars are considered to be a safe and effective alternative to the original biologics medications in the treatment of rheumatoid arthritis...
New Research on COVID-19 and Immunosuppressive Medications May Provide Answers for People with Rheumatic Diseases.
New Research on COVID-19 and Immunosuppressive Medications May Provide Answers for People with Rheumatic Diseases June 9, 2020 (Vancouver, BC) – Are people with Rheumatic Diseases who take immunosuppressive medications at a higher risk of getting COVID-19? Do people...
Research shows hydroxychloroquine has substantial survival benefit among patients with systemic lupus erythematosus in the general population
Research shows hydroxychloroquine has substantial survival benefit among patients with systemic lupus erythematosus in the general population May 20, 2020 (Vancouver, BC) – An Arthritis Research Canada study has revealed substantial survival benefit associated with...
Arthritis Research Canada new research to address impact of COVID-19 on medication use and mental health for people with arthritis
Arthritis Research Canada new research to address impact of COVID-19 on medication use and mental health for people with arthritis May 4, 2020 (Vancouver, BC) – Arthritis Research Canada’s research scientist Dr. Mary De Vera and her team have launched a new study,...
